RT Journal Article
SR Electronic
T1 Summary: Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP jnumed.123.265560
DO 10.2967/jnumed.123.265560
A1 Kevin J. Donohoe
A1 Brett J. Carroll
A1 David K.V. Chung
A1 Elizabeth H. Dibble
A1 Emilia Diego
A1 Francesco Giammarile
A1 Frederick D. Grant
A1 Stephen Y. Lai
A1 Hannah Linden
A1 Megan E. Miller
A1 Neeta Pandit-Taskar
A1 Nicholas E. Tawa, Jr.
A1 Sergi Vidal-Sicart
YR 2023
UL http://jnm.snmjournals.org/content/early/2023/03/23/jnumed.123.265560.abstract
AB Expert representatives from 11 professional societies, as part of an autonomous work group, researched and developed appropriate use criteria (AUC) for lymphoscintigraphy in sentinel lymph node mapping and lymphedema. The complete findings and discussions of the work group, including example clinical scenarios, were published on October 8, 2022, and are available at https://www.snmmi.org/ClinicalPractice/ content.aspx?ItemNumber=42021. The complete AUC document includes clinical scenarios for scintigraphy in patients with breast, cutaneous, and other cancers, as well as for mapping lymphatic flow in lymphedema. Pediatric considerations are addressed. These AUC are intended to assist health care practitioners considering lymphoscintigraphy. Presented here is a brief overview of the AUC, including the rationale and methodology behind development of the document. For detailed findings of the work group, the reader should refer to the complete AUC document online.